BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28262606)

  • 1. Adjuvant therapy in patients with ductal carcinoma in situ of the breast: The Pandora's box.
    Lazzeroni M; Dunn BK; Pruneri G; Jereczek-Fossa BA; Orecchia R; Bonanni B; DeCensi A
    Cancer Treat Rev; 2017 Apr; 55():1-9. PubMed ID: 28262606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ductal carcinoma in situ: a disease entity that merits more recognition.
    Dereere E; Papadimitriou K; Tjalma W; Altintas S
    Minerva Chir; 2015 Aug; 70(4):231-9. PubMed ID: 25916193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
    Sakorafas GH; Tsiotou AG
    Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Ductal Carcinoma In Situ of the Breast: A Review.
    Shah C; Wobb J; Manyam B; Kundu N; Arthur D; Wazer D; Fernandez E; Vicini F
    JAMA Oncol; 2016 Aug; 2(8):1083-8. PubMed ID: 27253401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current treatment trends and the need for better predictive tools in the management of ductal carcinoma in situ of the breast.
    Martínez-Pérez C; Turnbull AK; Ekatah GE; Arthur LM; Sims AH; Thomas JS; Dixon JM
    Cancer Treat Rev; 2017 Apr; 55():163-172. PubMed ID: 28402908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controversies in the Treatment of Ductal Carcinoma in Situ.
    Barrio AV; Van Zee KJ
    Annu Rev Med; 2017 Jan; 68():197-211. PubMed ID: 28099081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ductal carcinoma in situ, complexities and challenges.
    Leonard GD; Swain SM
    J Natl Cancer Inst; 2004 Jun; 96(12):906-20. PubMed ID: 15199110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary treatment of ductal carcinoma in situ of the breast.
    Mokbel K
    Med Sci Monit; 2005 Mar; 11(3):RA86-93. PubMed ID: 15735580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ductal carcinoma in situ.
    Bleicher RJ
    Surg Clin North Am; 2013 Apr; 93(2):393-410. PubMed ID: 23464692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal management of ductal carcinoma in situ of the breast.
    Sakorafas GH; Farley DR
    Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ductal Carcinoma In Situ: Treatment Update and Current Trends.
    Mitchell KB; Kuerer H
    Curr Oncol Rep; 2015 Nov; 17(11):48. PubMed ID: 26373411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards optimal management of ductal carcinoma in situ of the breast.
    Mokbel K
    Eur J Surg Oncol; 2003 Mar; 29(2):191-7. PubMed ID: 12633565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast-conserving treatment for ductal carcinoma in situ: Impact of boost and tamoxifen on local recurrences.
    Cutuli B; Wiezzane N; Palumbo I; Barbieri P; Guenzi M; Huscher A; Borghesi S; Delva C; Iannone T; Vianello E; Rosetto ME; Aristei C
    Cancer Radiother; 2016 Jun; 20(4):292-8. PubMed ID: 27344537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of ductal carcinoma in situ of the breast: review of recent advances and future prospects.
    Mokbel K
    Int J Fertil Womens Med; 2003; 48(5):217-25. PubMed ID: 14626378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of ductal carcinoma in situ after excision: would a prophylactic paradigm be more appropriate?
    Punglia RS; Schnitt SJ; Weeks JC
    J Natl Cancer Inst; 2013 Oct; 105(20):1527-33. PubMed ID: 24068769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic Assays in Ductal Carcinoma In Situ: Implications for Management Decisions.
    Gangi A; Topham A; Lee MC; Sun W; Laronga C
    South Med J; 2017 Oct; 110(10):649-653. PubMed ID: 28973706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in adjuvant therapies after breast-conserving surgery for hormone receptor-positive ductal carcinoma in situ: findings from the National Cancer Database, 2004-2013.
    Sagara Y; Freedman RA; Wong SM; Aydogan F; Nguyen A; Barry WT; Golshan M
    Breast Cancer Res Treat; 2017 Nov; 166(2):583-592. PubMed ID: 28776282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of subsequent invasive breast cancer after a diagnosis of ductal carcinoma in situ (DCIS).
    Cheung S; Booth ME; Kearins O; Dodwell D
    Breast; 2014 Dec; 23(6):807-11. PubMed ID: 25270228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances and current controversies in the management of DCIS of the breast.
    Sakorafas GH; Farley DR; Peros G
    Cancer Treat Rev; 2008 Oct; 34(6):483-97. PubMed ID: 18490111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National Breast Cancer Audit: ductal carcinoma in situ management in Australia and New Zealand.
    Cuncins-Hearn A; Boult M; Babidge W; Zorbas H; Villanueva E; Evans A; Oliver D; Kollias J; Reeve T; Maddern G
    ANZ J Surg; 2007; 77(1-2):64-8. PubMed ID: 17295824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.